Patient Selection Criteria and Management Guidelines for Outpatient Parenteral Antibiotic Therapy for Native Valve Infective Endocarditis
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Outpatient parenteral antibiotic therapy (OPAT) for infective endocarditis (IE) is being applied widely, despite the absence of controlled data that demonstrates that outcomes are equivalent to those with standard inpatient antibiotic therapy. We review existing OPAT guidelines, published data on the timing of complications from IE, and data on risk factors that can be used to predict complications. These data are used to propose more stringent criteria for patient selection and clinical management of OPAT for native valve IE. We recommend a conservative approach (inpatient or daily outpatient follow-up) during the critical phase (weeks 0-2 of treatment), when complications are most likely, and we recommend consideration of OPAT for the continuation phase (weeks 2-4 or 2-6 of treatment) when life-threatening complications are less likely.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Textbook of Cardiovascular Medicine
Topol, E. J. (1997) · Cited by 961
Daniel, W. G., Mügge, A., Martin, R. P., Lindert, O., Hausmann, D., Nonnast-Daniel, B., Laas, J., & Lichtlen, P. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241203 · Cited by 723 · cited 1×
“Transesophageal echocardiography has dramatically improved detection of perivalvular abscess, with a sensitivity of 87% and a specificity of 95%, compared with a sensitivity of 28% and a specificity of 99% for transthoracic echocardiography [80].”
BackgroundMügge, A., Daniel, W. G., Frank, G., & Lichtlen, P. R. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90104-6 · Cited by 654
Infective Endocarditis in the Antibiotic Era
Lerner, P. I., & Weinstein, L. (1966) · New England Journal of Medicine · doi:10.1056/nejm196601272740407 · Cited by 595 · cited 2×
“Heart failure due to valvular insufficiency is the leading complication of IE; it occurs in 15%–65% of cases [40, 52, 53, 63].”
BackgroundWilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492 · cited 2×
“According to the American Heart Association Guidelines for IE treatment [10], “inpatient therapy does not prevent.”
MethodNEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS
PRUITT, A. A., RUBIN, R. H., KARCHMER, A. W., & DUNCAN, G. W. (1978) · Medicine · doi:10.1097/00005792-197807000-00004 · Cited by 419
Emboli in Infective Endocarditis: The Prognostic Value of Echocardiography
Steckelberg, J. M., Murphy, J. G., Ballard, D., Bailey, K., Tajik, A. J., Taliercio, C. P., Giuliani, E. R., & Wilson, W. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-635 · Cited by 411 · cited 2×
“to those of mitral valve vegetations [66].”
BackgroundTreatment of infective endocarditis: a 10-year comparative analysis.
Richardson, J. V., Karp, R. B., Kirklin, J. W., & Dismukes, W. E. (1978) · Circulation · doi:10.1161/01.cir.58.4.589 · Cited by 362 · cited 1×
“aureus is the pathogen most often associated with abscess [39, 77].”
BackgroundSanfilippo, A. J., Picard, M. H., Newell, J. B., Rosas, E., Davidoff, R., Thomas, J. D., & Weyman, A. E. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90535-h · Cited by 328
Research works printed but not linked: 18
- Wilson WR, 1982, Mayo Clin Proc, 57, 162
- Dismukes WE, 1981, Philadelphia: FA Davis, 189
- Scheld WM, 1995, New York: Churchill Livingstone, 740
- Patton J. Infective endocarditis: economic considerations. In: Kaye D, ed. Infective endocarditis. New York: Raven Press, 1992:413-422.
- Gentry LO, 1989, Tex Heart Inst J, 16, 250
- Antoniskis A, 1978, West J Med, 128, 203
- Rehm SJ, 1986, New York: Marcel Dekker, 117
- Stiver HG, 1982, Can Med Assoc J, 127, 207
- Francioli PB, 1993, Philadelphia: WB Saunders, 97
- Kunkel MJ, 1996, Chicago: Scientific American, 60
- Rehm SJ, 1998, Philadelphia: WB Saunders, 879
- 10.1001/archinte.152.9.1863 · doi:10.1001/archinte.152.9.1863 · Paper page
- Karchmer AW. Staphylococcal endocarditis. In: Kaye D, ed. Infective endocarditis. New York: Raven Press, 1992:225-249.
- Thompson RL, 1982, Mayo Clin Proc, 57, 106
- Karchmer AW, 1997, Philadelphia: WB Saunders, 1077
- Levinson ME. Response to therapy. In: Kaye D, ed. Infective endocarditis. Baltimore: University Park Press, 1976:185-199.
- Wilson WR, 1982, Mayo Clin Proc, 57, 155
- Schaff HV, 1986, New York: Marcel Dekker, 229
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“These findings may be influenced by confounding factors, in particular changes in the number of patients at risk of hospitalizations and healthcare-associated IE.”
InfluentialBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“The timing for transition from inpatient antibiotic therapy to OPAT and patient exclusion criteria have been critically evaluated by Andrews and von Reyn.326 These guidelines are based on the local availability of medical care in the outpatient setting and risk factors and timing of potential adverse outcomes that wou…”
MethodGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Iversen, K., Ihlemann, N., Gill, S. U., Madsen, T., Elming, H., Jensen, K. T., Bruun, N. E., Høfsten, D. E., Fursted, K., Christensen, J. J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1808312 · Cited by 824
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaun, E., Pettersson, G. B., Schäfers, H. J., & Prendergast, B. D. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 715
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/420939 · Cited by 532
Update on Infective Endocarditis
Bashore, T. M., Cabell, C., & Fowler, Jr. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2005.12.001 · Cited by 227
Chapman, A. L. N., Seaton, R. A., Cooper, M. A., Hedderwick, S., Goodall, V., Reed, C., Sanderson, F., Nathwani, D., & on behalf of the BSAC/BIA OPAT Project Good Practice Recommendations Working Group (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks003 · Cited by 197
Endocarditis and Intravascular Infections
Saiman, L. (2008) · Principles and Practice of Pediatric Infectious Disease · doi:10.1016/b978-0-7020-3468-8.50045-6 · Cited by 177
2015 ESC Guidelines for the management of infective endocarditis
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0227 · Cited by 165
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 152
The infective endocarditis team: recommendations from an international working group
Chambers, J. B., Sandoe, J. A. T., Ray, S. G., Prendergast, B., Taggart, D. P., Westaby, S., Arden, C., Grothier, L., Wilson, J., Campbell, B., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304354 · Cited by 140
Current best practices and guidelines
Sexton, D. J., & Spelman, D. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00031-6 · Cited by 115
Ho, J., Archuleta, S., Sulaiman, Z., & Fisher, D. A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq355 · Cited by 99
The value of an “Endocarditis Team”
Davierwala, P. M., Cuartas, M. M., Misfeld, M., & Borger, M. A. (2019) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2019.09.03 · Cited by 99
“The Endocarditis Team in reference centers can facilitate the possibility of providing outpatient parenteral antibiotic treatment, which can help in shortening the length of stay in hospital for selected patients who have otherwise recovered from the surgical trauma and/ or the effects of IE (26-28).”
BackgroundOutpatient Parenteral Antimicrobial Therapy
Laupland, K. B., & Valiquette, L. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/205910 · Cited by 94
MacKenzie, M., Rae, N., & Nathwani, D. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.006 · Cited by 99
Current Challenges in the Management of Infective Endocarditis
Cuervo, G., Escrihuela-Vidal, F., Gudiol, C., & Carratalà, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641243 · Cited by 88
“A series of specific criteria must be met by the patients for them to be considered safe candidates for OPAT (156).”
BackgroundInfluentials, J. M. P., Llopis, J., Ramallo, V. J. G., Goenaga, M. Á., Muñóz, P., García-Leoni, M. E., Fariñas, M. C., Pajarón, M., Ambrosioni, J., Luque, R., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz030 · Cited by 83
Cervera, C., del Río, A., García, L., Sala, M., Almela, M., Moreno, A., Falces, C., Mestres, C. A., Marco, F., Robau, M., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.05.007 · Cited by 80
“CoNS 3 (7%) 3 (13%) 4 (50%) 10 (14%) NA 18 (13-26) Enterococcus spp 2 (5%) 4 (17%) 0 6 (8%) NA 24 (16-35)”
Treatment of Enterococcus faecalis Infective Endocarditis: A Continuing Challenge
Hidalgo, L. H., Fernández-Rubio, B., Márquez, R. L., López-Cortés, L. E., Gil-Navarro, M. V., & de Alarcón, A. (2023) · Antibiotics · doi:10.3390/antibiotics12040704 · Cited by 81
Muldoon, E. G., Snydman, D. R., Penland, E. C., & Allison, G. M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit211 · Cited by 75
Surgical management of valvular heart disease 2004.
Jamieson, W. R. E., Cartier, P. C., Allard, M., Boutin, C., Burwash, I. G., BUTANY, J. W., de Varennes, B., Rizzo, D. F. D., Dumesnil, J. G., Honos, G. N., et al. (2004) · PubMed · Cited by 86
Swedish guidelines for diagnosis and treatment of infective endocarditis
Westling, K., Aufwerber, E., Ekdahl, C., Friman, G., Gårdlund, B., Julander, I., Olaison, L., Olesund, C., Rundström, H., Snygg‐Martin, U., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701534517 · Cited by 66
Amodeo, M. R., Clulow, T., Lainchbury, J. G., Murdoch, D., Gallagher, K., Dyer, A., Metcalf, S. C. L., Pithie, A. D., & Chambers, S. T. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.009 · Cited by 64
Duncan, C. J. A., Barr, D. A., Ho, A. Y. W., Sharp, E., Semple, L., & Seaton, R. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt046 · Cited by 62
Rehm, S. J., Campion, M., Katz, D. E., Russo, R., & Boucher, H. W. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp051 · Cited by 63
“These include: hospitalization during the initial 2 week critical period (and possibly for a continuation phase of up to 2–4 weeks), patient education regarding potential complications as well as methods of contacting medical staff, proximity to the hospital, and biweekly office visits or home visits from the healthca…”
MethodHome Intravenous Antimicrobial Infusion Therapy: A Viable Option in Older Adults
Cox, A. M., Malani, P., Wiseman, S. W., & Kauffman, C. A. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01133.x · Cited by 64
Outpatient parenteral antimicrobial therapy with ceftriaxone, a review
Duncan, C. J. A., Barr, D. A., & Seaton, R. A. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9637-z · Cited by 56
“Ceftriaxone has been used for more than 20 years in streptococcal endocarditis [29, 37–44], with comparable efficacy to IPAT [29].”
BackgroundD’Couto, H. T., Robbins, G. K., Ard, K. L., Wakeman, S. E., Alves, J., & Nelson, S. B. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy056 · Cited by 55
“Characteristics in our study that were associated with adverse OPAT outcomes included lack of family involved in discharge planning, which is similar to what is seen in non-PWID settings [13].”
ResultPartridge, D. G., O'Brien, E., & Chapman, A. L. N. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130355 · Cited by 54
Tan, C., Shojaei, E., Wiener, J., Shah, M., Koivu, S. L., & Silverman, M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.12974 · Cited by 54
Muldoon, E. G., Switkowski, K. M., Tice, A. D., Snydman, D. R., & Allison, G. M. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.967290 · Cited by 55
An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort
Seetoh, T., Lye, D. C., Cook, A. R., Archuleta, S., Chan, M., Sulaiman, Z., Zhong, L., Llorin, R. M., Balm, M. N. D., & Fisher, D. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.01.015 · Cited by 54
“There is no evidence from this cohort that any diagnosis, including endocarditis [4,10], carries excessive risk, although patients were carefully scrutinised on a number of clinical variables prior to acceptance.”
BackgroundMethodSy, R. W., Chawantanpipat, C., Richmond, D. R., & Kritharides, L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp085 · Cited by 48
“Days 1, 8, and 15 were chosen as clinically important landmarks for abstracting the data because existing guidelines suggest that the first fortnight of hospitalization is a critical phase of illness during which complications occur frequently and important management decisions are often required.(2,3) At these time-p…”
Partial oral treatment of endocarditis
Iversen, K. K., Høst, N. B., Bruun, N. E., Elming, H., Pump, B., Christensen, J. J., Gill, S. U. A., Rosenvinge, F. S., Wiggers, H., Fuursted, K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.11.006 · Cited by 49
Outpatient parenteral antibiotic therapy in Singapore
Fisher, D. A., Kurup, A., Lye, D. C., Tambyah, P. A., Sulaiman, Z., Poon, E., Lee, W., Kaur, V. P., & Lim, P. L. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.018 · Cited by 45
Outpatient parenteral antimicrobial therapy for infective endocarditis: A cost-effective strategy
Lacroix, A., Revest, M., Patrat-Delon, S., Lemaitre, F., Donal, E., Lorleac’h, A., Arvieux, C., Michelet, C., & Tattevin, P. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.05.001 · Cited by 45
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N. (2004) · Journal of Infusion Nursing · doi:10.1097/00129804-200409000-00008 · Cited by 42
“Andrews and von Reyn [23] suggest that patients with uncomplicated endocarditis due to viridans group streptococci could be discharged to receive OPAT after 1 week of hospitalization.”
BackgroundOutcomes and Pharmacoeconomic Analysis of a Home Intravenous Antibiotic Infusion Program in Veterans
Ruh, C. A., Parameswaran, G. I., Wojciechowski, A. L., & Mergenhagen, K. A. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.09.009 · Cited by 42
Larioza, J., Heung, L. J., Girard, A. W., & Brown, R. B. (2009) · Southern Medical Journal · doi:10.1097/smj.0b013e3181a4eef2 · Cited by 38
Recent trends in infective endocarditis: influence of case definitions
Devlin, R. K., Andrews, M., & von Reyn, C. F. (2004) · Current Opinion in Cardiology · doi:10.1097/00001573-200403000-00012 · Cited by 44
Self-citationCurrent best practices and guidelines
Sexton, D. J., & Spelman, D. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00011-3 · Cited by 41
Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci
Cervera, C., Castañeda, X., Pericàs, J. M., del Río, A., de la Mària, C. G., Mestres, C. A., Falces, C., Marco, F., Moreno, A., & Miró, J. M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.038 · Cited by 36
Htin, A. K. F., Friedman, N. D., Hughes, A. J., O'Brien, D. P., Huffam, S., Redden, A. ‐., & Athan, E. (2013) · Internal Medicine Journal · doi:10.1111/imj.12081 · Cited by 34
“central venous catheter), absence of active illicit drug use, and consent from both patients and carers (16).”
BackgroundPajarón, M., Fernández-Miera, M. F., Allende, I., Arnáiz, A., Gutiérrez‐Cuadra, M., Cobo-Belaustegui, M., Armiñanzas, C., de Berrazueta, J. R., Fariñas, M. C., & Sanroma, P. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.01.001 · Cited by 37
Hidalgo, L. H., de Alarcón, A., López-Cortés, L. E., Márquez, R. L., López-Cortés, L. E., Gutiérrez‐Valencia, A., & Gil-Navarro, M. V. (2020) · Antibiotics · doi:10.3390/antibiotics9100657 · Cited by 32
Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?
McMahon, J. H., O’Keeffe, J., The Victorian Hith Outcomes Study, G., & Grayson, L. M. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701522942 · Cited by 33
“Inclusion criteria for HITH care were based on those previously published and were identical at all centres [1,2].”
BackgroundMethodExperience with Community‐Based Amphotericin B Infusion Therapy
Malani, P., DePestel, D. D., Riddell, J., Bickley, S. K., Klein, L. R., & Kauffman, C. A. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.5.690.63591 · Cited by 34
“Definite or probable fungal infection Candidiasis 25 (22) Aspergillosis 23 (20) Other filamentous fungi 5 (4) Histoplasmosis or coccidioidomycosis 3 (3) Possible fungal infection 32 (28) Empiric therapy 13 (12) Prophylaxis 13 (12)”
BackgroundEndocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00077-1 · Cited by 38
Nuclear Imaging in Infective Endocarditis
Mikaïl, N., & Hyafil, F. (2021) · Pharmaceuticals · doi:10.3390/ph15010014 · Cited by 27
“Outpatient parenteral antibiotic therapy is an option in stable patients with no evidence of complication [12,133].”
BackgroundWestphal, N., Plicht, B., & Naber, C. K. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0481 · Cited by 38
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 43
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J., Zotti, F. D., Dulgheru, R., Khoury, G. A. E., Erba, P. A., Iung, B., et al. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.11.015 · Cited by 54
Pericàs, J. M., Llopis, J., Muñóz, P., Ramallo, V. J. G., García-Leoni, M. E., de Alarcón, A., Luque, R., Fariñas, M. C., Goenaga, M. Á., Meneses, M. H., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac442 · Cited by 22
“aureus or other virulent organisms) [6].”
BackgroundResultPediatric Infective Endocarditis
Cox, D. A., & Tani, L. Y. (2020) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.06.011 · Cited by 24
Libertin, C. R., Çamsarı, U. M., Hellinger, W. C., Schneekloth, T. D., & Rummans, T. A. (2017) · IDCases · doi:10.1016/j.idcr.2017.02.001 · Cited by 19
“In this case, the primary disorder is the substance use disorder.”
Frieler, S., Hanusrichter, Y., Bellova, P., Geßmann, J., Schildhauer, T. A., & Baecker, H. (2020) · Journal of Orthopaedic Research® · doi:10.1002/jor.24906 · Cited by 18
Cervera, C., Sanroma, P., Ramallo, V. J. G., de la Mària, C. G., Sanclemente, G., Sopena, N., Pajarón, M., Segado, A., Mirón, M., Antón, F., et al. (2016) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2016.1247292 · Cited by 20
Outpatient Antimicrobial Therapy for Infective Endocarditis is Safe
Rajaratnam, D., & Rajaratnam, R. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.08.016 · Cited by 19
Durojaiye, O. C., Morgan, R., Chelaghma, N., & Kritsotakis, E. I. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.09.021 · Cited by 17
Li, W., Branley, J. M., & Sud, A. (2018) · Infection · doi:10.1007/s15010-018-1126-4 · Cited by 19
“Complication rates also vary significantly with causative organism, with Staphylococcus aureus being associated with higher mortality, valvular ring abscess, heart failure and central nervous system complications [16].”
BackgroundConnected care for endocarditis and heart failure patients: a hospital-at-home programme
van Ramshorst, J., Duffels, M. G. J., de Boer, S. P. M., Bos-Schaap, A. J. C. M., Drexhage, O., Walburg, S., de Beij, J., van der Stoop, D., & Umans, V. A. W. M. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01614-2 · Cited by 15
Kwok, C. S., Whittaker, J. J., Malbon, C., White, B., Snape, J., Lloyd, V., Yazdani, F., Kemp, T. S., & Duckett, S. G. (2021) · British Journal of Cardiology · doi:10.5837/bjc.2021.038 · Cited by 15
Wen, W., Li, H., Wang, C., Chen, C., Tang, J., Zhou, M., Hong, X., Cheng, Y., Wu, Q., Zhang, X., et al. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/011.2022 · Cited by 16
“recommended that patients with uncomplicated endocarditis caused by viridans group streptococci be discharged from hospital after 1 week to receive OPAT treatment [24].”
BackgroundPediatric Outpatient Parenteral Antimicrobial Therapy: An Update
Maraqa, N., & Rathore, M. H. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.09.002 · Cited by 17
“Patients with endocarditis who have infected prosthetic valves, persistently positive blood cultures, S aureus origin, large vegetations, conduction abnormality, or poorly controlled heart failure are usually poor candidates for outpatient management [1,22,70–73].”
BackgroundTratamiento antimicrobiano intravenoso en el domicilio
Ramallo, V. J. G., & Santiago, E. B. (2008) · Medicina Clínica · doi:10.1016/s0025-7753(08)72262-0 · Cited by 18
Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care
Rajaratnam, D., & Rajaratnam, R. (2023) · Antibiotics · doi:10.3390/antibiotics12020355 · Cited by 13
“Infective endocarditis has significant morbidity and mortality, where the first two weeks after diagnosis is the period of highest complication rate, and therefore an initial inpatient stabilization period is recommended [4,16,24].”
BackgroundPajarón, M., Lisa-Gracia, M., Fernández-Miera, M. F., Dueñas, J. C., Allende, I., Arnáiz, A., Sanroma, P., de Berrazueta, J. R., & Fariñas, M. C. (2017) · Hospital Practice · doi:10.1080/21548331.2017.1398588 · Cited by 13
“infectious process, it was incorporated into treatment under this care model at a late stage, whereby there is little prior experience in this regard [20, 24, 25].”
BackgroundCampbell, P. O., Gallagher, K., Dalton, S. C., Metcalf, S. C. L., Douglas, N. M., & Chambers, S. T. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.06.008 · Cited by 12
Strengths and limitations of patient registries in infective endocarditis
Escolà‐Vergé, L., Ribera, A., González, I. F., Pericàs, J. M., & Fernández‐Hidalgo, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.11.023 · Cited by 11
Safety of Outpatient Parenteral Antimicrobial Therapy for Endocarditis
Tice, A. D. (2002) · Clinical Infectious Diseases · doi:10.1086/324369 · Cited by 10
“Sir—Andrews and von Reyn [1] raise concerns about the use of outpatient parenteral antimicrobial therapy (OPAT) for endocarditis and provide reasonable recommendations for dealing with them.”
BackgroundMethodResultInfluentialNeisseria elongataendocarditis of a native aortic valve
Samannodi, M. S., Vakkalanka, S., Zhao, A., & Hocko, M. (2016) · BMJ Case Reports · doi:10.1136/bcr-2015-213311 · Cited by 10
A narrative review of the interpretation of guidelines for the treatment of infective endocarditis
Benedetto, U., Singh, S., Spadaccio, C., Moon, M. R., & Nappi, F. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3739 · Cited by 10
“OPAT is contraindicated in patients who have heart failure, complicated infection, high risk of embolism, neurological complications or renal insufficiency (45-47).”
BackgroundIn Vitro Synergism of Penicillin and Ceftriaxone against Enterococcus faecalis
Thieme, L., Briggs, S. E., Duffy, E., Makarewicz, O., & Pletz, M. W. (2021) · Microorganisms · doi:10.3390/microorganisms9102150 · Cited by 10
“Although a previous guideline for the Outpatient Parenteral Antibiotic Therapy (OPAT) treatment of IE was restrictive [5], a recent prospective cohort study has shown that the OPAT treatment of a broader range of patients with IE provided excellent results [6].”
ResultSurgical management of valvular heart disease
Grapsa, J., Dawson, D., Nihoyannopoulos, P., & Punjabi, P. P. (2010) · Medicine · doi:10.1016/j.mpmed.2010.07.011 · Cited by 10
Moreillon, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00047-2 · Cited by 11
Halpern, S. D., Abrutyn, E., & Strom, B. L. (2004) · Wiley eBooks · doi:10.1002/9780470988336.ch4 · Cited by 10
Hirai, Y., Ainoda, Y., Shoji, T., & Totsuka, K. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0033-0 · Cited by 8
“Because the once-daily dosing regimen recommended by the AHA allows outpatient therapy, OPAT with ceftriaxone or other drugs in patients with infectious endocarditis has been reported [ 13 , 17].”
BackgroundMethodInfluentialInfective Endocarditis: New Challenges in a Classic Disease
Cuervo, G., Meneses, M. H., Falces, C., Quintana, E., Vidal, B., Marco, F., Perissinotti, A., Carratalà, J., Miró, J. M., & The Hospital Clinic and the Hospital of Bellvitge Endocarditis Team Investigators (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1742482 · Cited by 6
Les actualités dans l’endocardite infectieuse
Parize, P., & Mainardi, J. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.10.007 · Cited by 9
Thelma Suau, C., Cecilia Piñera, M., Sergio Díaz, W., & Esteban Troncoso, R. (2008) · Revista chilena de infectología · doi:10.4067/s0716-10182008000500011 · Cited by 7
Endocarditis and Other Intravascular Infections
Levasseur, S. M., & Saiman, L. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00037-2 · Cited by 7
Outpatient parenteral antimicrobial therapy
Bellamy, R. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.1.12 · Cited by 7
Endocarditis in the 21(st) Century.
Baluta, M. M., Benea, E. O., Stanescu, C. M., & VINTILA, M. M. (2011) · PubMed · Cited by 8
Căliman-Sturdza, O. A. (2024) · Infectious diseases · doi:10.5772/intechopen.114918 · Cited by 5
Delahaye, F. (2012) · EMC - Cardiologie · doi:10.1016/s1166-4568(12)57330-4 · Cited by 5
Keys, T. F. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00107-7 · Cited by 4
Distant embolisation in infective endocarditis: characteristics and outcomes
Duffels, M. G. J., Germans, T., Bos-Schaap, A. J. C. M., Drexhage, O., Wagenaar, J. F. P., van der Zant, F. M., Hoogewerf, M., Knol, R. J. J., & Umans, V. A. W. M. (2023) · Netherlands Heart Journal · doi:10.1007/s12471-023-01771-6 · Cited by 4
Khoury, A., & Rattanasuwan, T. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.endocarditis_overview · Cited by 4
Chien, S., Gorman, D., Koutsogiannidis, C.-P. C., Ravishankar, R., Kamath, G. S., & Zamvar, V. (2019) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-019-0993-9 · Cited by 4
Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: Insights From Real Life
Tattevin, P., & Revest, M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz027 · Cited by 5
New Insights and Updates for Established Entities
(2003) · Springer eBooks · doi:10.1007/0-306-47926-5_1 · Cited by 4
A Bundle of the Top 10 OPAT Publications in 2022
Childs‐Kean, L. M., Beieler, A. M., Coroniti, A.-M., Cortes-Penfield, N. W., Keller, S. C., Mahoney, M. V. G., Rajapakse, N., Rivera, C. G., Yoke, L. H., & Ryan, K. L. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad283 · Cited by 3
“International criteria describing which patients with infective endocarditis (IE) may receive OPAT are restrictive [19].”
BackgroundHoen, B., Tornos, P., Antunes, M. J., Lekakis, J. P., Lengyel, M., Naber, C. K., & Zamorano, J. L. (2009) · Cited by 3
Endocarditis and Other Intravascular Infections
Levasseur, S. M., & Saiman, L. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00037-4 · Cited by 3
Tratamento ambulatorial da endocardite bacteriana estreptocócica
Sobrinho, S. H., Marchi, C. H. D., Croti, U. A., de Souza, C. G., da Silva, É. V. C. M., & de Godoy, M. F. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010000400025 · Cited by 3
Treatment Options for Gram-Positive and Gram-Negative Bacteria: Focus on Ceftriaxone
Hirai, Y. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1612 · Cited by 3
Outpatient Parenteral Antimicrobial Therapy
Bowling, J. E., Lewis, J. S., & Owens, A. D. (2012) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2012.07.002 · Cited by 3
“addition, patients may have persistent fever and bacteremia.(4) The median duration of bacteremia in a recent study was 8 to 9 days with methicillin-resistant Staphylococus aureus (MRSA) bacteremia and 3 to 4 days with methicillin-sensitive S aureus (MSSA) bacteremia while on therapy.”
BackgroundInfluential
Metadata
- Authors
- Andrews, M., & von Reyn, C. F.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07-15
- Volume
- 33
- Issue
- 2
- Pages
- 203-209
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2129274686
- Cited by
- 129
- References
- 82
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 2 · 2013: 11 · 2012: 7
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
- Keywords
- outpatient parenteral antibiotic therapy, infective endocarditis, native valve endocarditis, patient selection criteria, treatment phases, risk factors, conservative treatment, antibiotic therapy
- MeSH terms
- Anti-Bacterial Agents, Endocarditis, Bacterial, Health Planning Guidelines, Heart Valves, Humans, Outpatients, Practice Guidelines as Topic, Patient Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.